Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fatigue in immune thrombocytopenia
Quentin A. Hill, Adrian C. Newland
British Journal of Haematology (2015) Vol. 170, Iss. 2, pp. 141-149
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert, Deirdra R. Terrell, Donald M. Arnold, et al.
Blood Advances (2019) Vol. 3, Iss. 23, pp. 3829-3866
Open Access | Times Cited: 989
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan, Donald M. Arnold, James B. Bussel, et al.
Blood Advances (2019) Vol. 3, Iss. 22, pp. 3780-3817
Open Access | Times Cited: 837
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
Anne Zufferey, Rick Kapur, John W. Semple
Journal of Clinical Medicine (2017) Vol. 6, Iss. 2, pp. 16-16
Open Access | Times Cited: 451
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
Adrian C. Newland, Blanca Sánchez‐González, László Rejtő, et al.
American Journal of Hematology (2019) Vol. 95, Iss. 2, pp. 178-187
Open Access | Times Cited: 141
Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
Hanny Al‐Samkari, David J. Kuter
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 81
Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia
Charlotte Bradbury, Julie Pell, Quentin A. Hill, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 10, pp. 885-895
Open Access | Times Cited: 79
Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment
Nichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
American Journal of Hematology (2020) Vol. 96, Iss. 2, pp. 188-198
Open Access | Times Cited: 77
Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
Anurag Singh, Günalp Uzun, Tamam Bakchoul
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 789-789
Open Access | Times Cited: 63
Epidemiology and Clinical Manifestations of Immune Thrombocytopenia
Rahil Kohli, Shruti Chaturvedi
Hämostaseologie (2019) Vol. 39, Iss. 03, pp. 238-249
Closed Access | Times Cited: 75
Immune Thrombocytopenia in Adults: Modern Approaches to Diagnosis and Treatment
Hanny Al‐Samkari, David J. Kuter
Seminars in Thrombosis and Hemostasis (2019) Vol. 46, Iss. 03, pp. 275-288
Open Access | Times Cited: 68
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology.
Giovanna Russo, Emilia Parodi, Piero Farruggia, et al.
PubMed (2024) Vol. 22, Iss. 3, pp. 253-265
Closed Access | Times Cited: 7
Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective
Daniel Martínez‐Carballeira, Ángel Bernardo, Alberto Caro, et al.
Hematology Reports (2024) Vol. 16, Iss. 2, pp. 204-219
Open Access | Times Cited: 7
Immune thrombocytopenia: improving quality of life and patient outcomes
Patrick Trotter, Quentin A. Hill
Patient Related Outcome Measures (2018) Vol. Volume 9, pp. 369-384
Open Access | Times Cited: 50
Immune thrombocytopenia
James B. Bussel, Nichola Cooper, Ralph V. Boccia, et al.
Expert Review of Hematology (2021) Vol. 14, Iss. 11, pp. 1013-1025
Open Access | Times Cited: 35
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study
Nichola Cooper, A.J. Gerard Jansen, Robert Bird, et al.
American Journal of Hematology (2025) Vol. 100, Iss. 3, pp. 439-449
Open Access
Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
David J. Kuter, James B. Bussel, Waleed Ghanima, et al.
Therapeutic Advances in Hematology (2023) Vol. 14
Open Access | Times Cited: 11
Second-line therapies in immune thrombocytopenia
Rachael F. Grace, Cindy Neunert
Hematology (2016) Vol. 2016, Iss. 1, pp. 698-706
Open Access | Times Cited: 38
Management of immune thrombocytopenia in women: current standards and special considerations
Francesco Rodeghiero, Ettore Marranconi
Expert Review of Hematology (2020) Vol. 13, Iss. 2, pp. 175-185
Closed Access | Times Cited: 28
Fatigue in children and adolescents with immune thrombocytopenia
Rachael F. Grace, Robert J. Klaassen, Kristin A. Shimano, et al.
British Journal of Haematology (2020) Vol. 191, Iss. 1, pp. 98-106
Open Access | Times Cited: 28
All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial
Qiu-Sha Huang, Yi Liu, Jingbo Wang, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 10, pp. e688-e699
Closed Access | Times Cited: 24
Health-related quality of life in adult primary immune thrombocytopenia
Hanna Gran Sestøl, Sine Munch Trangbæk, James B. Bussel, et al.
Expert Review of Hematology (2018) Vol. 11, Iss. 12, pp. 975-985
Closed Access | Times Cited: 26
Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists
Lamya Garabet, Waleed Ghanima, Anbjørg Rangberg, et al.
Platelets (2019) Vol. 31, Iss. 2, pp. 198-205
Open Access | Times Cited: 25
An update on pediatric ITP: differentiating primary ITP, IPD, and PID
Rachael F. Grace, Michele P. Lambert
Blood (2021) Vol. 140, Iss. 6, pp. 542-555
Open Access | Times Cited: 19
Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy
Giovanni Caocci, Olga Mulas, Susanna Barella, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2547-2547
Open Access | Times Cited: 7
Immune Thrombocytopenia
Qian Li, Johan Rebetz, Drew Provan, et al.
(2024), pp. 1105-1112
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top